Akums Drugs & Pharmaceuticals Ltd (AKUMS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039335, "name": "Akums Drugs", "stock_name": "Akums Drugs", "full_name": "Akums Drugs & Pharmaceuticals Ltd", "name_url": "stocks-analysis/akums-drugs", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "662.55", "chg": -3.55, "chgp": "-0.53%", "dir": -1, "prev_price": "666.10", "mcapval": "10,467.00 Cr", "mcap": "Small Cap", "scripcode": "544222", "symbol": "AKUMS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE09XN01023", "curr_date": "Aug 06, 03:30 PM", "curr_time": "00:40 AM", "last_traded_at": "Aug 06, 03:30 PM IST", "bse_nse_vol": "1.05 lacs", "exc_status": "Active", "traded_date": "Aug 06, 2026", "traded_date_str": "2026 08 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/akums-drugs-10039335-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "When is the next results date for Akums Drugs & Pharmaceuticals Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-akums-drugs-pharmaceuticals-ltd-4140709", "imagepath": "", "date": "2026-08-06 23:20:53", "description": "The next results date for Akums Drugs & Pharmaceuticals Ltd is scheduled for August 8, 2026...." }, { "title": "Akums Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Changing Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-valuation-shifts-signal-changing-price-attractiveness-4136986", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AkumsDrugsPharm_valuationdot_4136986.png", "date": "2026-08-05 08:03:56", "description": "Akums Drugs & Pharmaceuticals Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid a challenging Pharmaceuticals & Biotechnology sector, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now aligning more closely with historical and peer averages. Investors are advised to consider these valuation dynamics alongside Akums’ robust operational metrics and recent market performance." }, { "title": "Akums Drugs & Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-pharmaceuticals-ltd-is-rated-hold-4132414", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AkumsDrugsPharm_mojoScore_4132414.png", "date": "2026-08-02 10:10:03", "description": "Akums Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 August 2026, providing investors with an up-to-date perspective on its performance and outlook." }, { "title": "Akums Drugs & Pharmaceuticals Ltd: Valuation Shift Enhances Price Attractiveness Amid Sector Dynamics", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-valuation-shift-enhances-price-attractiveness-amid-sector-dynamics-4121832", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AkumsDrugsPharm_valuationdot_4121832.png", "date": "2026-07-27 08:01:49", "description": "Akums Drugs & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change reflects a more compelling price proposition for investors, especially when analysed against historical averages and peer benchmarks within the Pharmaceuticals & Biotechnology sector." }, { "title": "Akums Drugs & Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-pharmaceuticals-ltd-is-rated-hold-4115163", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AkumsDrugsPharm_mojoScore_4115163.png", "date": "2026-07-22 10:10:03", "description": "Akums Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO. This rating was last updated on 10 April 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here are based on the stock's current position as of 22 July 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Akums Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4111569", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AkumsDrugsPharm_valuationdot_4111569.png", "date": "2026-07-21 08:02:37", "description": "Akums Drugs & Pharmaceuticals Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, prompting a reassessment of its price appeal among investors. This change comes amid robust stock performance and improving financial metrics, positioning the company favourably within the Pharmaceuticals & Biotechnology sector." }, { "title": "Akums Drugs & Pharmaceuticals Ltd Falls 5.21%: Valuation Shifts and Technical Signals Shape Weekly Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-falls-521-valuation-shifts-and-technical-signals-shape-weekly-trend-4106881", "imagepath": "", "date": "2026-07-18 10:01:17", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Jul:</strong> New 52-week high of Rs.713.8 reached</p>\n <p><strong>13 Jul:</strong> Valuation grade shifted from very attractive to fair</p>\n <p><strong>17 Jul:</strong> Week closes at Rs.665.10, down 5.21%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.701.65</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.665.10</div><div class=\"stat-change negative\">-5.21%</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Wee..." }, { "title": "Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 713.8", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-hits-new-52-week-high-of-rs7138-4098067", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AkumsDrugsPharm_priceRelatedfactors_4098067.png", "date": "2026-07-13 09:52:49", "description": "From a 52-week low of Rs 410.1 to a fresh high of Rs 713.8, Akums Drugs & Pharmaceuticals Ltd has delivered a robust 25.6% return over the past year, significantly outperforming the Sensex which declined by 6.41% in the same period. This rally, culminating in a new 52-week peak on 13 Jul 2026, is underpinned by a strong alignment of technical indicators and sustained price momentum." }, { "title": "Akums Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Changing Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-valuation-shifts-signal-changing-price-attractiveness-4097697", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AkumsDrugsPharm_valuationdot_4097697.png", "date": "2026-07-13 08:01:23", "description": "Akums Drugs & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a previously very attractive price-to-earnings (P/E) ratio to a fair valuation band. Despite this adjustment, the company’s stock has delivered robust returns year-to-date, significantly outperforming the Sensex and its pharmaceutical peers. This article analyses the recent valuation changes, compares Akums’ metrics with industry benchmarks, and assesses the implications for investors." } ], "total": 229, "sid": "10039335", "stock_news_url": "https://www.marketsmojo.com/news/akums-drugs-pharmaceuticals-10039335" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "08 Aug 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Akums Drugs & Pharmaceuticals Ltd has declared <strong>50%</strong> dividend, ex-date: 03 Jul 26", "dt": "2026-07-03", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

13 Jul: New 52-week high of Rs.713.8 reached

13 Jul: Valuation grade shifted from very attractive to fair

17 Jul: Week closes at Rs.665.10, down 5.21%

Read full news article

Broad-Based Technical Strength Lifts Akums Drugs & Pharmaceuticals Ltd to 52-Week High of Rs 713.8

2026-07-13 09:52:49

From a 52-week low of Rs 410.1 to a fresh high of Rs 713.8, Akums Drugs & Pharmaceuticals Ltd has delivered a robust 25.6% return over the past year, significantly outperforming the Sensex which declined by 6.41% in the same period. This rally, culminating in a new 52-week peak on 13 Jul 2026, is underpinned by a strong alignment of technical indicators and sustained price momentum.

Read full news article

Akums Drugs & Pharmaceuticals Ltd: Valuation Shifts Signal Changing Price Attractiveness

2026-07-13 08:01:23

Akums Drugs & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a previously very attractive price-to-earnings (P/E) ratio to a fair valuation band. Despite this adjustment, the company’s stock has delivered robust returns year-to-date, significantly outperforming the Sensex and its pharmaceutical peers. This article analyses the recent valuation changes, compares Akums’ metrics with industry benchmarks, and assesses the implications for investors.

Read full news article